Dopamine D4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals - PubMed (original) (raw)
Affiliations
- PMID: 9454795
Dopamine D4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals
R A Wilke et al. J Pharmacol Exp Ther. 1998 Feb.
Abstract
Dopamine influences the release of neurohypophysial peptides in vivo. However, the extent to which this effect is caused by a direct dopaminergic action within the neurohypophysis remains unclear. With use of the patch-clamp technique on thin slices of rat posterior pituitary glands, we now provide evidence that dopaminergic agonists inhibit potassium current (IK) in neurohypophysial nerve terminals. Superfusion with the dopamine receptor agonist, (+/-)-2-(N-phenylethyl-N-propyl)-amino-5-hydroxytetralin (PPHT), causes a reversible inhibition of whole-terminal IK under voltage clamp. This effect is concentration-dependent, with a maximal inhibition of 40 +/- 5% and an EC50 of 1.8 +/- 1.0 microM. It can be blocked with either a nonselective D2-like antagonist (100 microM eticlopride) or with the highly selective D4 antagonist, RBI-257 (10 microM). U101958 (a derivative of RBI-257) exhibits agonist activity similar to PPHT. Neither SKF 38393 (a D1/D5 agonist) nor quinpirole (a D2/D3 agonist) had any effect on whole-terminal IK in this preparation. Kinetic analysis demonstrated that the amplitude of both the rapidly and slowly inactivating phases of neurohypophysial IK are reduced by D4 receptor activation. These two separate current components have previously been shown to represent current through two distinct potassium channels, an A-current channel and a high-conductance Ca++-activated K+ channel. Thus, both channel types can be modulated by D4 receptors. This effect is likely to enhance the release of neurohypophysial peptides in vivo.
Similar articles
- D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD. Ramanathan S, et al. J Neurophysiol. 2008 Feb;99(2):442-59. doi: 10.1152/jn.00998.2007. Epub 2007 Dec 19. J Neurophysiol. 2008. PMID: 18094105 - D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
Liu LX, Burgess LH, Gonzalez AM, Sibley DR, Chiodo LA. Liu LX, et al. Synapse. 1999 Feb;31(2):108-18. doi: 10.1002/(SICI)1098-2396(199902)31:2<108::AID-SYN3>3.0.CO;2-V. Synapse. 1999. PMID: 10024007 - Dopamine D4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus.
Azdad K, Piet R, Poulain DA, Oliet SH. Azdad K, et al. J Neurophysiol. 2003 Aug;90(2):559-65. doi: 10.1152/jn.00226.2003. Epub 2003 Apr 23. J Neurophysiol. 2003. PMID: 12711714 - Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4-receptor analysis?
Zawilska JB, Nowak JZ. Zawilska JB, et al. Pol J Pharmacol. 1997 Aug;49(4):201-11. Pol J Pharmacol. 1997. PMID: 9437763 Review. - Membrane excitability in the neurohypophysis.
Wilke RA, Ahern GP, Jackson MB. Wilke RA, et al. Adv Exp Med Biol. 1998;449:193-200. doi: 10.1007/978-1-4615-4871-3_25. Adv Exp Med Biol. 1998. PMID: 10026805 Review.
Cited by
- Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine.
Hussy N, Brès V, Rochette M, Duvoid A, Alonso G, Dayanithi G, Moos FC. Hussy N, et al. J Neurosci. 2001 Sep 15;21(18):7110-6. doi: 10.1523/JNEUROSCI.21-18-07110.2001. J Neurosci. 2001. PMID: 11549721 Free PMC article. - Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.
Lupardus PJ, Wilke RA, Aydar E, Palmer CP, Chen Y, Ruoho AE, Jackson MB. Lupardus PJ, et al. J Physiol. 2000 Aug 1;526 Pt 3(Pt 3):527-39. doi: 10.1111/j.1469-7793.2000.00527.x. J Physiol. 2000. PMID: 10922005 Free PMC article. - K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors.
Wilke RA, Lupardus PJ, Grandy DK, Rubinstein M, Low MJ, Jackson MB. Wilke RA, et al. J Physiol. 1999 Jun 1;517 ( Pt 2)(Pt 2):391-406. doi: 10.1111/j.1469-7793.1999.00391.x. J Physiol. 1999. PMID: 10332090 Free PMC article. - Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P. Gazi L, et al. Br J Pharmacol. 1999 Oct;128(3):613-20. doi: 10.1038/sj.bjp.0702849. Br J Pharmacol. 1999. PMID: 10516640 Free PMC article. - The dopamine D4 receptor: biochemical and signalling properties.
Rondou P, Haegeman G, Van Craenenbroeck K. Rondou P, et al. Cell Mol Life Sci. 2010 Jun;67(12):1971-86. doi: 10.1007/s00018-010-0293-y. Epub 2010 Feb 18. Cell Mol Life Sci. 2010. PMID: 20165900 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical